# FDA Inspection 1173461 - Cadila Pharmaceuticals Limited - June 17, 2022

Source: https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/5d7e1807-c56a-449f-95fe-2e7563d70d00
Source feed: FDA_Inspections

> FDA Inspection 1173461 for Cadila Pharmaceuticals Limited on June 17, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1173461
- Company Name: Cadila Pharmaceuticals Limited
- Inspection Date: 2022-06-17
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1293740 - 2025-09-26](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/140a3822-4398-4af1-9f69-6778fa4a952d)
- [FDA Inspection 1293740 - 2025-09-26](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/b991c75a-8fa3-4de4-8f98-9277d2ebe1a8)
- [FDA Inspection 1205061 - 2023-04-07](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/b255ba0d-baeb-4fb6-ae1a-18089e5910b3)
- [FDA Inspection 1120482 - 2020-02-14](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/2033cf38-309c-4e24-a5ed-94b5fdf1206e)
- [FDA Inspection 1052117 - 2018-05-03](https://www.globalkeysolutions.net/records/fda_inspections/cadila-pharmaceuticals-limited/63f78d34-ad1d-4b85-87a0-067d7502a5cd)

Company: https://www.globalkeysolutions.net/companies/cadila-pharmaceuticals-limited/ea4ece29-89c9-42f3-9afa-58348dc605b9

Office: https://www.globalkeysolutions.net/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c